---
title: Wired focuses on GLP-1 patient fallout
description: Wired looks at how some patients are being hit hard by tirzepatide coming off shortage.
---

[APC in the News ](https://a4pc.org/inthenews)

# [Wired focuses on GLP-1 patient fallout](https://a4pc.org/inthenews/2024-10/wired-focuses-on-glp-1-patient-fallout)

 Written by [Andrew](https://a4pc.org/inthenews/author/andrew) | Oct 09, 2024

Kudos to Wired for its piece, “[A Major GLP-1 Drug Shortage Is Over. Some Patients Aren’t Celebrating](https://www.wired.com/story/glp-1-shortage-mounjaro-zepbound-tirzepatide-compounded/).” It’s all about how patients who have gotten used to the price and availability of compounded tirzepatide are now facing a double whammy of not being able to get the commercial version, and even if they can, the sticker shock hits hard.

[View full post](https://a4pc.org/inthenews/2024-10/wired-focuses-on-glp-1-patient-fallout)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Andrew"
  },
  "dateModified" : "2025-02-04T22:11:00.451Z",
  "datePublished" : "2024-10-09T13:54:53Z",
  "headline" : "Wired focuses on GLP-1 patient fallout",
  "image" : {
    "@type" : "ImageObject",
    "height" : 60,
    "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
    "width" : 60
  },
  "mainEntityOfPage" : "https://a4pc.org/inthenews/2024-10/wired-focuses-on-glp-1-patient-fallout",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "APC in the News"
  }
}
```